Viewing Study NCT00212459



Ignite Creation Date: 2024-05-05 @ 12:01 PM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00212459
Status: COMPLETED
Last Update Posted: 2013-03-27
First Post: 2005-09-13

Brief Title: The Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding Logs
Sponsor: New York Presbyterian Hospital
Organization: New York Presbyterian Hospital

Study Overview

Official Title: A Prospective Randomized Pilot Study on the Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding Logs
Status: COMPLETED
Status Verified Date: 2008-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The study will see if counselling adolescents with severe or moderate Hemophilia A or B results in increased compliance in the maintenance of bleeding logs
Detailed Description: The study will see if counselling adolescents with severe or moderate Hemophilia A or B results in increased compliance in the maintenance of bleeding logsTo do this subjects will be randomized into a control group and a group who will receive consistent counselling by a pharmacist about their bleeding logs

The aims of the study are

To provide a new method of bleeding and treatment documentation in the home setting logs to adolescent subjects with Hemophilia A or B
To counsel these subjects about adherence to their treatment regimen prescribed by physician and the importance of keeping accurate documentation of each bleeding episode and its treatment
To improve maintenance of logs to allow for 1 assessment of bleeding frequency and treatment efficacy and 2 early detection of target joint bleeding and the potential need for prophylactic factor replacement

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None